NCT01480661View on ClinicalTrials.gov

Evaluation With CT Scan of Possible Changes in Airways After Treatment With Daxas® in Severe Chronic Obstructive Pulmonary Disease Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Roflumilast

Roflumilast 500 µg, once a day in the morning during 6 months

DRUG

Placebo of Roflumilast

Placebo 500 µg, once a day in the morning during 6 months

RADIATION

Functional Respiratory Imaging

CT scan of thorax, at baseline and after 6 months

Trial Locations (2)

2020

ZNA Middelheim, Antwerp

2650

Antwerp University Hospital, Edegem

Sponsors

Lead Sponsor

FLUIDDA nv
All Listed Sponsors
lead

FLUIDDA nv

INDUSTRY